Ruthee-LuBayerMD

Oncology • Lake Success, NY

Assistant Professor, Medicine, Hofstra North Shore-LIJ

Join to view full profile

Dr. Bayer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bayer's full profile

Already have an account?

Office
The Monter Cancer Center
450 Lakeville Road
Lake Success, NY 11042
Phone+1 516-734-8973

Fax+1 516-734-8836

Education & Training

Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 1995 - 1998
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1992 - 1995
New York Medical CollegeClass of 1992

Certifications & Licensure

NY State Medical License 1994 - 2026
American Board of Internal Medicine Internal Medicine

Clinical Trials

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Start of enrollment: 2010 Oct 01
Active, not recruiting
Phase 3
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Dec 14
Completed
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance Start of enrollment: 2011 Oct 28
Completed
Phase 2
Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma Start of enrollment: 2012 Dec 01
Active, not recruiting
Phase 2
AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Start of enrollment: 2021 Mar 29
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

25 citations
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
Alex F. Herrera, Kwang Woo Ahn, Carlos Litovich, Yue Chen, Amer Assal
Blood Advances. 2021-09-28
10 citations
Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia
John M. Pagel, Megan Othus, Guillermo Garcia-Manero, Min Fang, Jerald P. Radich
JCO Oncology Practice. 2020-01-27
12 citations
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study
Michael A. Pulsipher, Brent R. Logan, Pintip Chitphakdithai, Deidre M. Kiefer, Marcie L. Riches
Biology of Blood and Marrow Transplantation. 2019-04-01